Literature DB >> 15640403

Prevention of contrast media-induced nephrotoxicity after angiographic procedures.

Sameh K Morcos1.   

Abstract

Contrast medium-induced nephrotoxicity (ie, contrast nephrotoxicity [CN]) remains an important complication of angiographic procedures. If administration of iodinated contrast medium is deemed necessary in patients at high risk of CN, volume expansion should be offered and the lowest possible dose of nonionic isosmolar dimeric or nonionic low-osmolar monomeric contrast medium should be used. Prophylactic administration of fenoldopam or acetylcysteine has not offered consistent protection against CN. Intravenous acetylcysteine could be considered in emergency situations. Recently, sodium bicarbonate infusion has been shown to reduce the risk of CN. Hemofiltration for several hours before and after contrast medium injection may offer good protection against CN in patients with advanced renal disease. Prophylactic hemodialysis does not offer any protection against CN.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15640403     DOI: 10.1097/01.RVI.0000145224.02920.C2

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  15 in total

Review 1.  [Multidetector computed tomography in the diagnosis of non-traumatic vascular emergencies].

Authors:  B Baumert; M Körner; M Sadeghi-Azandaryani; C Rummeny; M Reiser; U Linsenmaier
Journal:  Radiologe       Date:  2009-06       Impact factor: 0.635

2.  Joint quality improvement guidelines for pediatric arterial access and arteriography: from the Societies of Interventional Radiology and Pediatric Radiology.

Authors:  Manraj K S Heran; Francis Marshalleck; Michael Temple; Clement J Grassi; Bairbre Connolly; Richard B Towbin; Kevin M Baskin; Josee Dubois; Mark J Hogan; Sanjoy Kundu; Donald L Miller; Derek J Roebuck; Steven C Rose; David Sacks; Manrita Sidhu; Michael J Wallace; Darryl A Zuckerman; John F Cardella
Journal:  Pediatr Radiol       Date:  2010-02

Review 3.  CT and radiation-related cancer risk-time for a paradigm shift?

Authors:  David A Johnson; Paul R Helft; Douglas K Rex
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12       Impact factor: 46.802

4.  Electromagnetic navigation for thoracic aortic stent-graft deployment: a pilot study in swine.

Authors:  Nadine Abi-Jaoudeh; Neil Glossop; Michael Dake; William F Pritchard; Alberto Chiesa; Matthew R Dreher; Thomas Tang; John W Karanian; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2010-04-09       Impact factor: 3.464

Review 5.  Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Authors:  Fulvio Stacul; Aart J van der Molen; Peter Reimer; Judith A W Webb; Henrik S Thomsen; Sameh K Morcos; Torsten Almén; Peter Aspelin; Marie-France Bellin; Olivier Clement; Gertraud Heinz-Peer
Journal:  Eur Radiol       Date:  2011-08-25       Impact factor: 5.315

6.  Radiographic assessment of splenic injury without contrast: is contrast truly needed?

Authors:  Douglas R Murken; Joshua J Weis; Geoffrey C Hill; Louis H Alarcon; Matthew R Rosengart; Raquel M Forsythe; Gary T Marshall; Timothy R Billiar; Andrew B Peitzman; Jason L Sperry
Journal:  Surgery       Date:  2012-08-31       Impact factor: 3.982

Review 7.  Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines.

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2006-05-04       Impact factor: 5.315

8.  Low rate of contrast-induced Nephropathy after CT perfusion and CT angiography in acute stroke patients.

Authors:  R Dittrich; S Akdeniz; S P Kloska; T Fischer; M A Ritter; P Seidensticker; W Heindel; E B Ringelstein; D G Nabavi
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

9.  Atherosclerotic Peripheral Vascular Disease Symposium II: vascular magnetic resonance and computed tomographic imaging.

Authors:  Shellie C Josephs; Howard A Rowley; Geoffrey D Rubin
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

10.  Can selective inhibitors of cyclic guanosine monophosphate (cGMP)-specific phosphadiesterase type 5 (PDE 5) offer protection against contrast induced nephropathy?

Authors:  Sameh K Morcos
Journal:  Quant Imaging Med Surg       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.